Got diagnosed June and had the pleurectomy in August at Eastern Virginia Medical Center. Doing okay recovery-wise. Now I'm looking at a couple clinical trials and honestly there's a lot of noise out there.
I was on the Oriskany from '71 to '91 as a hull tech, so asbestos exposure was just part of the job back then. Nobody knew. Anyway, that's water under the bridge.
Here's what I'm trying to figure out. When you're looking at trials, what's actually worth paying attention to versus what's just marketing. One trial is at Duke, one's at UNC. Both say they're looking at stage II patients. Duke's protocol involves chemotherapy first then some kind of immunotherapy combo. UNC's is immunotherapy only. The Duke trial has been running since 2019, UNC started in 2023.
I'm not afraid of chemo. I served with guys who went through way worse. But I want to know if I'm picking based on real data or just because one center has a better reputation. The trial coordinators are friendly enough but they're selling the trial, you know. That's their job.
What did people actually look at when they made this call. Case numbers. How long patients stayed on the drug. Whether they could keep working or if the side effects knocked you flat. I'm still working part time as a consultant and I'd like to keep doing that if I can.
Anybody else done this with stage II pleural.